Leganto

Medicinal product

(Invented) name

Leganto

Active substance (s)

Rotigotinas

Strength

8 mg/24 h

Pharmaceutical form

transderminis pleistras

Route (s) of administration

vartoti per odą

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N04BC09, Rotigotine

Marketing authorisation holder

UCB Pharma S.A., Belgija

Date of authorisation

2011-06-16

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10c

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Transdermal patch	1 vnt.
Rotigotinas	8 mg/24 h

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
47476	61293	1061293	paketėlis	N7		Receptinis	EU/1/11/695/046	Netiekiama	-	-	No	-	-
47478	61295	1061295	paketėlis	N28		Receptinis	EU/1/11/695/048	Netiekiama	-	-	No	-	-
47479	61296	1061296	paketėlis	N30		Receptinis	EU/1/11/695/049	Netiekiama	-	-	No	-	-
47482	61299	1061299	paketėlis	N84 (sudėtinė 2x42)		Receptinis	EU/1/11/695/052	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-12-13	Išregistruotas
2011-06-16	Registruotas